Scandinavian ChemoTech AB (publ) announced that it has been granted its third and last patent application by The Patent Office, Government of India. The approved patent application pertains to the utilization of TSE for pain alleviation. The Patent Office, Government of India has approved the third and final patent application.

This approval allows for the utilization of TSE by delivering dynamic electrical pulses with pinpoint accuracy to specific body parts of mammals, enabling effective pain management, in amongst others deep seated tumours. The protection extends to 2038.